Sun exposure and mortality from melanoma.

BACKGROUND Melanoma incidence and survival are positively associated, both geographically and temporally. Solar elastosis, a histologic indicator of cutaneous sun damage, has also been positively associated with melanoma survival. Although these observations raise the possibility that sun exposure increases melanoma survival, they could be explained by an association between incidence and early detection of melanoma. We therefore evaluated the association between measures of skin screening and death from cutaneous melanoma. METHODS Case subjects (n = 528) from a population-based study of cutaneous melanoma were followed for an average of more than 5 years. Data, including measures of intermittent sun exposure, perceived awareness of the skin, skin self-screening, and physician screening, were collected during in-person interviews and review of histopathology and histologic parameters (i.e., solar elastosis, Breslow thickness, and mitoses) for all of the lesions. Competing risk models were used to compute risk of death (hazard ratios [HRs], with 95% confidence intervals [CIs]) from melanoma. All statistical tests were two-sided. RESULTS Sunburn, high intermittent sun exposure, skin awareness histories, and solar elastosis were statistically significantly inversely associated with death from melanoma. Melanoma thickness, mitoses, ulceration, and anatomic location on the head and neck were statistically significantly positively associated with melanoma death. In a multivariable competing risk analysis, skin awareness (with versus without, HR = 0.5, 95% CI = 0.3 to 0.9, P = .022) and solar elastosis (present versus absent, HR = 0.4, 95% CI = 0.2 to 0.8, P = .009) were strongly and independently associated with melanoma death after adjusting for Breslow thickness, mitotic index, and head and neck location, which were also independently associated with death. CONCLUSIONS Sun exposure is associated with increased survival from melanoma.

[1]  R. Gallagher,et al.  Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma , 2005, International journal of cancer.

[2]  William J Blot,et al.  Sunlight and reduced risk of cancer: is the real story vitamin D? , 2005, Journal of the National Cancer Institute.

[3]  H. Adami,et al.  Ultraviolet radiation exposure and risk of malignant lymphomas. , 2005, Journal of the National Cancer Institute.

[4]  N. Gruis,et al.  Familial melanoma: a complex disorder leading to controversy on DNA testing , 2004, Familial Cancer.

[5]  Mark R Wick,et al.  Protocol for the examination of specimens from patients with melanoma of the skin. , 2009, Archives of pathology & laboratory medicine.

[6]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[7]  V. Gebski,et al.  Patterns of metastases in familial and non-familial melanoma , 2003, Melanoma research.

[8]  Mitchell H Gail,et al.  Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. , 2002, Cancer research.

[9]  D. Trump,et al.  Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells. , 2002, Endocrinology.

[10]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[11]  G. Severi,et al.  The body site distribution of melanocytic naevi in 6–7 year old European children , 2001, Melanoma research.

[12]  Andrew G Smith,et al.  Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[14]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[15]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[16]  J Cuzick,et al.  Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.

[17]  D. Whiteman,et al.  p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.

[18]  J. Mark Elwood,et al.  Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.

[19]  T. Holford,et al.  Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.

[20]  M. Berwick,et al.  Predicting five‐year outcome for patients with cutaneous melanoma in a population‐based study , 1996, Cancer.

[21]  N. Martin,et al.  Accuracy of case‐reported family history of melanoma in Queensland, Australia , 1996, Melanoma research.

[22]  K. Klaamas,et al.  IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting , 1996, International journal of cancer.

[23]  C. Begg,et al.  Screening for cutaneous melanoma by skin self-examination. , 1996, Journal of the National Cancer Institute.

[24]  A. Verbeek,et al.  An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. , 1995, Journal of clinical epidemiology.

[25]  L. Padovani,et al.  Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 2. Challenge with bleomycin. , 1995, Mutation research.

[26]  J. Lefebvre,et al.  Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. , 1995, Cancer letters.

[27]  B. Armstrong,et al.  How much melanoma is caused by sun exposure? , 1993, Melanoma research.

[28]  Michael C. Minnotte,et al.  Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.

[29]  C. Holman,et al.  Survival among patients with clinical stage i cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981 , 1991, Cancer.

[30]  L. Ries,et al.  Effect of Changes in Cancer Classification and the Accuracy of Cancer Death Certificates on Trends in Cancer Mortality , 1990, Annals of the New York Academy of Sciences.

[31]  R. Gray A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[32]  B K Armstrong,et al.  Melanoma of the skin. , 1984, British medical bulletin.

[33]  C. Holman,et al.  Survival from preinvasive and invasive malignant melanoma in Western Australias , 1983, Cancer.

[34]  T. Larsen,et al.  A Retrospective Histological Study of 669 Cases of Primary Cutaneous Malignant Melanoma in Clinical Stage I , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[35]  Lancaster Ho,et al.  Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .